4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-020663
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sandoval Elisabeth · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-19 | Grant or award : show line 1 in the form Stock Option | +45,000 | $2.67 | 2030-03-19 | 45,000 | 45,000 | D |
Loading xslF345X03/doc4.xml…